Acuta Capital Partners, LLC Enanta Pharmaceuticals Inc Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$38.13 - $76.93 $960,876 - $1.94 Million
25,200 Added 1095.65%
27,500 $1.3 Million
Q1 2022

May 16, 2022
BUY
$56.06 - $74.11 $128,938 - $170,453
2,300 New
2,300 $164,000
Q2 2019

Aug 14, 2019
SELL
$81.3 - $97.35 $4.96 Million - $5.94 Million
-61,000 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$69.08 - $105.66 $4.21 Million - $6.45 Million
61,000 New
61,000 $5.83 Million

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.2M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $115M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email